Cardiovascular complications associated with novel angiogenesis inhibitors: Emerging evidence and evolving perspectives
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference65 articles.
1. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity;Alon;Nature Medicine,1995
2. Home blood-pressure monitoring in patients receiving sunitinib;Azizi;New England Journal of Medicine,2008
3. Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling;Baffert;American Journal of Physiology: Heart and Circulatory Physiology,2006
4. Cooperation between VEGF and TNF-alpha is necessary for exposure of active tissue factor on the surface of human endothelial cells;Camera;Arteriosclerosis, Thrombosis, and Vascular Biology,1999
5. Cardiomyocyte PDGFR-beta signaling is an essential component of the mouse cardiac response to load-induced stress;Chintalgattu;Journal of Clinical Investigation,2010
Cited by 101 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The incidence and relative risk of major adverse cardiovascular events and hypertension in patients treated with immune checkpoint inhibitors plus tyrosine-kinase inhibitors for solid tumors: a systemic review and meta-analysis;Expert Review of Anticancer Therapy;2024-06-16
2. Use of new and emerging cancer drugs: what the cardiologist needs to know;European Heart Journal;2024-04-09
3. Cardiovascular Concerns, Cancer Treatment, and Biological and Chronological Aging in Cancer;JACC: CardioOncology;2024-04
4. Novel insights into cardiovascular toxicity of cancer targeted and immune therapies: Beyond ischemia with non-obstructive coronary arteries (INOCA);American Heart Journal Plus: Cardiology Research and Practice;2024-04
5. Management of cancer patients at high and very-high risk of cardiotoxicity: Main questions and answers;Current Problems in Cardiology;2024-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3